Loading clinical trials...
Loading clinical trials...
Velcade (Bortezomib) and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma
Conditions
Interventions
Velcade and Sorafenib
Locations
3
United States
University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
The Cancer Center at Presbyterian
Albuquerque, New Mexico, United States
Memorial Medical Center- Cancer Center
Las Cruces, New Mexico, United States
Start Date
April 1, 2010
Primary Completion Date
January 1, 2014
Completion Date
February 1, 2015
Last Updated
September 17, 2015
NCT06391099
NCT07227415
NCT06835972
NCT07175480
NCT05700461
NCT05122546
Lead Sponsor
New Mexico Cancer Research Alliance
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions